|
|
Suppliers for
Ceritinib
|
Properties | CAS |
1032900-25-6 | Formula |
C28H36ClN5O3S |
|
10 Registered suppliers
More details are to be found here
Molecular Formula: C28H36ClN5O3S Molecular Weight: 558.13514
Molecular Formula: C28H36ClN5O3S Molecular Weight: 558.13514
Molecular Formula: C28H36ClN5O3S Molecular Weight: 558.13514
More details are to be found here
Description : An anaplastic lymphoma kinase (ALK)-positive inhibitor used for the treatment of non-small cell lung cancer (NSCLC). It less potently inhibits IGF-1R, InsR, and STK22D and IC50 value is 8, 7, and 23 nM. LDK378 is also minimally effective against a panel of other kinases. In Sep 2016, Interim adverse events and efficacy data from phase III ASCEND-4 trial in non small cell lung cancer released by Novartis. In Oct 2016, efficacy data from the phase III ASCEND-3 and ASCEND-5 trial in non small cell lung cancer was presented. - Molecular Weight :558.14
- Purity :≥98%
Molecular Formula : C28H36ClN5O3S Canonical SMILES : CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl InChI : InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34) InChIKey : VERWOWGGCGHDQE-UHFFFAOYSA-N Solubility : Soluble in DMSO. Appearance : Solid Powder Application : Antineoplastic Agents Storage : Store at -20ºC Synonyms : 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine, LDK-378, LDK378; LDK 378; Zykadia; NVP-LDK378-NX
More details are to be found here
Description : An anaplastic lymphoma kinase (ALK)-positive inhibitor used for the treatment of non-small cell lung cancer (NSCLC). It less potently inhibits IGF-1R, InsR, and STK22D and IC50 value is 8, 7, and 23 nM. LDK378 is also minimally effective against a panel of other kinases. In Sep 2016, Interim adverse events and efficacy data from phase III ASCEND-4 trial in non small cell lung cancer released by Novartis. In Oct 2016, efficacy data from the phase III ASCEND-3 and ASCEND-5 trial in non small cell lung cancer was presented. - Molecular Weight :558.14
- Purity :≥98%
Molecular Formula : C28H36ClN5O3S Canonical SMILES : CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl InChI : InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34) InChIKey : VERWOWGGCGHDQE-UHFFFAOYSA-N Solubility : Soluble in DMSO. Appearance : Solid Powder Application : Antineoplastic Agents Storage : Store at -20ºC Synonyms : 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine, LDK-378, LDK378; LDK 378; Zykadia; NVP-LDK378-NX
More details are to be found here
Detailed information on the suppliers of
Ceritinib
|
Properties:
... more properties and specification on Ceritinib
|
|
Privileged suppliers
Last update 2024-06-21
|